PDE4A and chronic obstructive pulmonary disease: At present, the strategy for COPD treatment focuses on down-regulating airway smooth-muscle tone using bronchodilators and reducing pulmonary inflammation using inhaled corticosteroids or the phosphodiesterase type 4 (PDE4) inhibitors (e.g., roflumilast)6.